Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCgamma-receptor-II-mediated mechanism and by drugs.

MLA

Vervoordeldonk, S. F., et al. “Degradation of Radioiodinated B Cell Monoclonal Antibodies: Inhibition via a FCgamma-Receptor-II-Mediated Mechanism and by Drugs.” Cancer Immunology, Immunotherapy : CII, vol. 42, no. 1, Jan. 1996, pp. 24–30. EBSCOhost, https://doi.org/10.1007/s002620050247.

APA

Vervoordeldonk, S. F., Balkenende, A. Y., van den Berg, H., von dem Borne, A. E., van der Schoot, C. E., Van Leeuwen, E. F., & Slaper-Cortenbach, I. C. (1996). Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCgamma-receptor-II-mediated mechanism and by drugs. Cancer Immunology, Immunotherapy : CII, 42(1), 24–30. https://doi.org/10.1007/s002620050247

Chicago

Vervoordeldonk, S F, A Y Balkenende, H van den Berg, A E von dem Borne, C E van der Schoot, E F Van Leeuwen, and I C Slaper-Cortenbach. 1996. “Degradation of Radioiodinated B Cell Monoclonal Antibodies: Inhibition via a FCgamma-Receptor-II-Mediated Mechanism and by Drugs.” Cancer Immunology, Immunotherapy : CII 42 (1): 24–30. doi:10.1007/s002620050247.